TDR Research Rates Trulieve Cannabis A 'Buy', Potential 46% Stock Price Upside
TDR Research has recently initiated coverage of multi-state cannabis company Trulieve (OTC: TCNNF), assigning it a “Buy” rating based on an extensive analysis of the company's financial health and growth potential.
